{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T12:00:34Z","timestamp":1776686434668,"version":"3.51.2"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["306358\/2022-0 e 305330\/2022-5"],"award-info":[{"award-number":["306358\/2022-0 e 305330\/2022-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.abd.2026.501324","type":"journal-article","created":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T07:27:36Z","timestamp":1774250856000},"page":"501324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["JAK inhibitors in livedoid vasculopathy associated with thrombophilia and refractory to anticoagulation: report and literature review"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9785-6099","authenticated-orcid":false,"given":"Giulia Jardim","family":"Criado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paulo Ricardo","family":"Criado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Lorenzini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9lio Amante","family":"Miot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2026.501324_bib0005","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.autrev.2010.11.008","article-title":"Livedoid vasculopathy as a coagulation disorder","volume":"10","author":"Criado","year":"2011","journal-title":"Autoimmun Rev."},{"key":"10.1016\/j.abd.2026.501324_bib0010","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.abd.2024.09.004","article-title":"Livedoid vasculopathy, calciphylaxis, and martorell\u2019s hypertensive ulcer: update on ischemic ulcers due to impaired microcirculation of the lower limbs","volume":"100","author":"Lacerda","year":"2025","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2026.501324_bib0015","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1001\/archderm.134.4.447","article-title":"Livedo vasculopathy vs small vessel cutaneous vasculitis: cytokine and platelet P-selectin studies","volume":"134","author":"Papi","year":"1998","journal-title":"Arch Dermatol."},{"key":"10.1016\/j.abd.2026.501324_bib0020","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1111\/cup.13043","article-title":"Analysis of serum levels and cutaneous expression of lipoprotein (a) in 38 patients with livedoid vasculopathy","volume":"44","author":"Espinel","year":"2017","journal-title":"J Cutan Pathol."},{"key":"10.1016\/j.abd.2026.501324_bib0025","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(10)60709-X","article-title":"Antiphospholipid syndrome","volume":"376","author":"Ruiz-Irastorza","year":"2010","journal-title":"Lancet."},{"key":"10.1016\/j.abd.2026.501324_bib0030","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.phrs.2017.02.001","article-title":"Lipoprotein(a) and inflammation: a dangerous duet leading to endothelial loss of integrity","volume":"119","author":"Pirro","year":"2017","journal-title":"Pharmacol Res."},{"key":"10.1016\/j.abd.2026.501324_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.102311","article-title":"Type I interferon gene expression in antiphospholipid syndrome: pathogenetic, clinical and therapeutic implications","volume":"104","author":"Xourgia","year":"2019","journal-title":"J Autoimmun."},{"key":"10.1016\/j.abd.2026.501324_bib0040","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.anndiagpath.2017.06.002","article-title":"Lymphocytic thrombophilic arteritis: a distinct inflammatory type I interferon and C5b-9 mediated subcutaneous endovasculitis","volume":"31","author":"Magro","year":"2017","journal-title":"Ann Diagn Pathol."},{"key":"10.1016\/j.abd.2026.501324_bib0045","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.abd.2023.03.001","article-title":"JAK-STAT pathway inhibitors in dermatology","volume":"98","author":"Miot","year":"2023","journal-title":"An Bras Dermatol."},{"key":"10.1016\/j.abd.2026.501324_bib0050","doi-asserted-by":"crossref","first-page":"9338","DOI":"10.1007\/s12035-025-04834-4","article-title":"Investigating the potential therapeutic targeting of the JAK-STAT pathway in cerebrovascular diseases: opportunities and challenges","volume":"62","author":"Wu","year":"2025","journal-title":"Mol Neurobiol."},{"key":"10.1016\/j.abd.2026.501324_bib0055","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2025.2451804","article-title":"Janus kinase inhibitors and biologics for treatment of livedoid vasculopathy: a systematic review","volume":"36","author":"Liu","year":"2025","journal-title":"J Dermatolog Treat."}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059626000371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059626000371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T11:15:58Z","timestamp":1776683758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059626000371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0365059626000371"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2026.501324","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"JAK inhibitors in livedoid vasculopathy associated with thrombophilia and refractory to anticoagulation: report and literature review","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2026.501324","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"501324"}}